Use of Vedolizumab in UC

Dan Joseph Stein; Salina Faidhalla

doi:10.1007/978-3-031-48949-5_36

Back

Shared by

Dan Joseph Stein

Use of Vedolizumab in UC

Chapter In A Book 2023 en

Authors

Dan Joseph Stein
SF
Salina Faidhalla

Related publications

Article2017

Higher Vedolizumab Levels are Associated with Deep Remission in Patients with Crohn's Disease and Ulcerative Colitis on Maintenance Therapy with Vedolizumab

Andrés Yarur, Alexandra Bruss, Anjali Jain, Venkateswarlu Kondragunta, Theresa L. Luna, Kelly Hester, Amir Patel, Dilpesh Agrawal, Caroline S. Fox, Shannon L. Werner, Snehal Naik, Dan Joseph Stein

Discussion(0)

Sign in to like and join the discussion.

No comments yet. Be the first to comment.

Chapter in a book2023

UC in a Patient Who Failed Mesalamine and Anti-TNF

Dan Joseph Stein, Salina Faidhalla

Conference paper2021

Süreç İyileştirmede Değişimin Üç Yüzü: Kaizen, Kaikaku, Kakushin

M. Mustafa Yücel, Ebru Oskaloğlu

Article2002

Intestinal absorption characteristics of the low solubility thiocarboxanilide UC-781

S. Deferme, J. Van Gelder, F. Ingels, Guy Van den Mooter, Stijn De Buck, Jan Balzarini, Lieve Naesens, De Clercq Erik, Renaat Kinget, Patrick Augustijns

Article1998

The thiocarboxanilide UC-781 is a potential virucidal drug

Jan Balzarini, Lieve Naesens, Eric Verbeken, M. Laga, L. Van Damme, M Verstraeten, Lieve Van Mellaert, Jozef Anné, De Clercq Erik